Related Experiment Video
Updated: Dec 31, 2025
08:49
Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples
Published on: January 13, 2023
2.2K
Liquid Biopsy Applications in the Clinic
Dake Chen1, Tao Xu2, Shubin Wang3
1Department of Oncology, Tongzhou People's Hospital, Nantong, 226300, China.
Molecular Diagnosis & Therapy
|January 11, 2020
Summary
Liquid biopsies analyze biomarkers like cell-free DNA in patient samples for disease diagnosis. This minimally invasive technology is advancing clinical applications and personalized medicine.
Area of Science:
- Biotechnology
- Molecular Diagnostics
- Oncology
Background:
- The global liquid biopsy market is rapidly expanding, projected to surpass $5 billion by 2023.
- Liquid biopsies detect disease biomarkers (DNA, RNA, protein, cells) in patient samples like blood and urine.
- Cell-free DNA in plasma is a key emerging biomarker for minimally invasive diagnostics.
Purpose of the Study:
- To review current clinical applications of liquid biopsy technology.
- To explore the future role of liquid biopsies in personalized medicine.
- To highlight advancements driving the diverse applications of liquid biopsies.
Main Methods:
- Review of existing literature on liquid biopsy applications.
- Analysis of technological developments in biomarker detection.
- Discussion of clinical case studies and future projections.
Main Results:
- Liquid biopsies are increasingly utilized for disease diagnosis across various sample types.
- Cell-free DNA analysis shows significant promise for non-invasive clinical assessment.
- Technological progress is expanding the scope and utility of liquid biopsies.
Conclusions:
- Liquid biopsies represent a significant advancement in minimally invasive diagnostics.
- The integration of liquid biopsies into personalized medicine is expected to grow.
- Continued technological innovation will further enhance the clinical impact of liquid biopsies.
